معرفی
Jessica Burris is an Assistant Professor in the Department of Psychiatry at Yale School of Medicine. Her research focuses on inflammatory bowel diseases (IBD), particularly comparing treatment efficacy and patient-reported outcomes of biologic therapies like vedolizumab and ustekinumab in anti-TNF-experienced Crohn’s disease patients. She also investigates systemic corticosteroid risks and population-based IBD outcomes.
Dr. Burris completed her MD at Vanderbilt University School of Medicine (2019) and a BA at University of Virginia. Her work emphasizes real-world evidence and patient-centered approaches, leveraging large-scale datasets such as the Crohn’s and Colitis Foundation of America Partners network to advance outcomes research.
Notable awards include the Founder’s Medal (Vanderbilt, 2019) and Beauchamp Prize in Psychiatry (Vanderbilt University Medical Center, 2019). She has contributed to 7 peer-reviewed publications since 2016, addressing topics ranging from biologic therapy comparisons to digital health innovations in chronic disease management.
